HUMAN PANCREATIC-ISLET BETA-CELL DESTRUCTION BY CYTOKINES IS INDEPENDENT OF NITRIC-OXIDE PRODUCTION

被引:120
作者
RABINOVITCH, A
SUAREZPINZON, WL
STRYNADKA, K
SCHULZ, R
LAKEY, JRT
WARNOCK, GL
RAJOTTE, RV
机构
[1] UNIV ALBERTA, DEPT PEDIAT, EDMONTON T6G 2S2, AB, CANADA
[2] UNIV ALBERTA, DEPT PHARMACOL, EDMONTON T6G 2S2, AB, CANADA
[3] UNIV ALBERTA, DEPT SURG, EDMONTON T6G 2S2, AB, CANADA
[4] UNIV ALBERTA, MUTTART DIABET RES & TRAINING CTR, EDMONTON T6G 2S2, AB, CANADA
关键词
D O I
10.1210/jc.79.4.1058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The inflammatory cytokines, interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma are cytotoxic to human islet beta-cells in vitro. To determine the possible role of nitric oxide (NO) as a mediator of cytokine-induced islet beta-cell destruction, we studied the relationships between NO production and destruction of human pancreatic islet cells incubated with cytokines in vitro. The cytokine combination of interleukin-1 beta (50 U/mL), tumor necrosis factor-alpha (10(3) U/mL), and interferon-gamma (10(3) U/mL) induced a significant increase in NO production and significant decreases in DNA and insulin contents of the islet cell cultures after a 48-h incubation. L-N-G-Monomethyl arginine, an inhibitor of NO synthase, completely prevented cytokine-induced NO production during incubations of 18, 36, 60, and 84 h. Cytokine-induced decreases in DNA and insulin contents of the islet cell cultures, however, were unaffected by the NO synthase inhibitor. Conversely, nicotinamide prevented cytokine-induced islet beta-cell destruction without inhibiting NO production. We conclude that cytokine-induced NO production in human islet cells may be neither necessary nor sufficient to destroy the islet beta-cells and that cytotoxic mechanisms, independent of NO, exist and can be inhibited by nicotinamide.
引用
收藏
页码:1058 / 1062
页数:5
相关论文
共 32 条
[11]   MECHANISMS OF NICOTINAMIDE AND THYMIDINE PROTECTION FROM ALLOXAN AND STREPTOZOCIN TOXICITY [J].
LEDOUX, SP ;
HALL, CR ;
FORBES, PM ;
PATTON, NJ ;
WILSON, GL .
DIABETES, 1988, 37 (08) :1015-1019
[12]  
MANDRUPPOULSEN T, 1987, J IMMUNOL, V139, P4077
[13]   WHAT ARE THE TYPES AND CELLULAR SOURCES OF FREE-RADICALS IN THE PATHOGENESIS OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
MANDRUPPOULSEN, T ;
CORBETT, JA ;
MCDANIEL, ML ;
NERUP, J .
DIABETOLOGIA, 1993, 36 (05) :470-471
[14]  
MANDRUPPOULSEN T, 1990, CURR TOP MICROBIOL, V164, P169
[15]   LIPOSOMAL DELIVERY OF PURIFIED HEAT-SHOCK PROTEIN HSP70 INTO RAT PANCREATIC-ISLETS AS PROTECTION AGAINST INTERLEUKIN-1-BETA-INDUCED IMPAIRED BETA-CELL FUNCTION [J].
MARGULIS, BA ;
SANDLER, S ;
EIZIRIK, DL ;
WELSH, N ;
WELSH, M .
DIABETES, 1991, 40 (11) :1418-1422
[16]   DESCRIPTIVE AND MECHANISTIC CONSIDERATIONS OF INTERLEUKIN-1 AND INSULIN-SECRETION [J].
MCDANIEL, ML ;
HUGHES, JH ;
WOLF, BA ;
EASOM, RA ;
TURK, JW .
DIABETES, 1988, 37 (10) :1311-1315
[17]   ETHIDIUM FLUORESCENCE ASSAYS .1. PHYSICOCHEMICAL STUDIES [J].
MORGAN, AR ;
LEE, JS ;
PULLEYBLANK, DE ;
MURRAY, NL ;
EVANS, DH .
NUCLEIC ACIDS RESEARCH, 1979, 7 (03) :547-569
[18]  
PIEPER GM, 1992, DIABETES S1, V41, pA158
[19]   PANCREATIC B-CELLS POSSESS DEFENSE-MECHANISMS AGAINST CELL-SPECIFIC TOXICITY [J].
PIPELEERS, D ;
VANDEWINKEL, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (14) :5267-5271
[20]   NICOTINAMIDE BIOLOGICAL ACTIONS AND THERAPEUTIC POTENTIAL IN DIABETES PREVENTION - IDIG WORKSHOP, COPENHAGEN, DENMARK, 4-5 DECEMBER 1992 [J].
POCIOT, F ;
REIMERS, JI ;
ANDERSEN, HU .
DIABETOLOGIA, 1993, 36 (06) :574-576